|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.756
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.663
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.650
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.605
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.528
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.497
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.481
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.429
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.389
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.367
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.363
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.355
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.346
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.336
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.322
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.306
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.298
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.285
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.281
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.273
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.262
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.246
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.245
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.231
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.228
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.210
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.210
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.207
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.203
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.201
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.199
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.197
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.196
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.193
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.189
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.183
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.179
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.177
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.172
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.170
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.165
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.155
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.150
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.148
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.147
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.144
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.143
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.142
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.141
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.141
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.139
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.138
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.138
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.136
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.133
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.132
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.129
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.128
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.128
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.126
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.124
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.123
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.123
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.123
|
|
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
4 |
0.122
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.121
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.120
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.119
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.119
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.118
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.118
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.116
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.112
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.110
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.109
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.108
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.107
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.106
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.106
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.106
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.103
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.099
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.098
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.098
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.097
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.097
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.096
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.091
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.091
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.089
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.088
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.088
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.087
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.087
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.087
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.085
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.083
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.083
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.082
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.082
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.080
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.079
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.078
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.077
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.076
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.075
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.075
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.075
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.074
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.074
|
|
|
|
regulation of sarcomere organization
|
GO:0060297 |
4 |
0.073
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.073
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.073
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.072
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.072
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.072
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.071
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.069
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.068
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.068
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.068
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.068
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.067
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.067
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.067
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.067
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.066
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.065
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.064
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.063
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.062
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.062
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.061
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.060
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.060
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.059
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.059
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.058
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.058
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.058
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.058
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.056
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.055
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.055
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.055
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.055
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.054
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.054
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.053
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.053
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.053
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.053
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.052
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.052
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.052
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.052
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.051
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.051
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.050
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.050
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.050
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.050
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.050
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.049
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.048
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.048
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.048
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.048
|
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.048
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.048
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.048
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.047
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.047
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.046
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.046
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.046
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.045
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.045
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.045
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.044
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.044
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.044
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.044
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.044
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.044
|
|
|
|
cellular response to testosterone stimulus
|
GO:0071394 |
1 |
0.043
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.043
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.043
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.042
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.042
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.042
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.042
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.042
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.041
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.041
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.041
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.041
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.041
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.041
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.040
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.040
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.040
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.040
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.040
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.039
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.039
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.038
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.038
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.038
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.038
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.038
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.038
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.037
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.037
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.037
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.037
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.037
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.037
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.037
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.036
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.035
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.035
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.035
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.035
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.035
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.035
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.034
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.034
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.034
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.034
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.033
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.033
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.033
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.033
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.033
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.033
|
|
|
|
regulation of circadian sleep wake cycle rem sleep
|
GO:0042320 |
1 |
0.033
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.033
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.033
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.032
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.032
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.032
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.032
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.032
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.031
|
|
|
|
regulation of relaxation of muscle
|
GO:1901077 |
8 |
0.031
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.031
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.031
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.031
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.030
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.030
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.030
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.030
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.030
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.030
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.029
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.029
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.029
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.029
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.029
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.029
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.029
|
|
|
|
cellular modified amino acid biosynthetic process
|
GO:0042398 |
12 |
0.028
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.028
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.028
|
|
|
|
cellular response to food
|
GO:0071240 |
1 |
0.028
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.028
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.028
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.028
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.028
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.028
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.028
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.028
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.028
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.028
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.028
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.028
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.027
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.027
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.027
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.027
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.027
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.027
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
9 |
0.027
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.027
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.027
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.026
|
|
|
|
skeletal muscle myosin thick filament assembly
|
GO:0030241 |
1 |
0.026
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.026
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.026
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.026
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.026
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.026
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.026
|
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.026
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.025
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.025
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.025
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.025
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.025
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.025
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.025
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.024
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.024
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.024
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.024
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.024
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.024
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.024
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.024
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.024
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.024
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.023
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.023
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.023
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.023
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.023
|
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
5 |
0.023
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.023
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.023
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.023
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.023
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.023
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.022
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.022
|
|
|
|
learning
|
GO:0007612 |
98 |
0.022
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.022
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.022
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.022
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.022
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.022
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.022
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.022
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.022
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.022
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.021
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.021
|
|
|
|
myotube differentiation involved in skeletal muscle regeneration
|
GO:0014908 |
2 |
0.021
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.021
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.021
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.021
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.021
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.021
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.021
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.021
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.021
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.021
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.021
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.020
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.020
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.020
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.020
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.020
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.020
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.020
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.020
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.020
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.020
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.020
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
cytokinetic process
|
GO:0032506 |
2 |
0.019
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.019
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.019
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.019
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.019
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.019
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.019
|
|
|
|
left ventricular cardiac muscle tissue morphogenesis
|
GO:0003220 |
2 |
0.019
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.018
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.018
|
|
|
|
detection of mechanical stimulus
|
GO:0050982 |
27 |
0.018
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.018
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.018
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.018
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.018
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.018
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.018
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.018
|
|
|
|
baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001982 |
2 |
0.018
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.018
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.018
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.018
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.018
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.018
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.018
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.018
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.018
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.018
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.017
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.017
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.017
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.017
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.017
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.017
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.017
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.017
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.017
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.017
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.017
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.017
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.017
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.017
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.017
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.016
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.016
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.016
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.016
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.016
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.016
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.016
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.016
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.016
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.016
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
l glutamate import into cell
|
GO:1990123 |
3 |
0.016
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.016
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.016
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.016
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.016
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.016
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.016
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.016
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.016
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.015
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.015
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.015
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.015
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.015
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.015
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.015
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.015
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.015
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
20 |
0.015
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.015
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.015
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.015
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.015
|
|